J. Strickland Recalls Subpotent Sulfur8 Anti-Dandruff Conditioner
J. Strickland and Co is recalling Sulfur8 Medicated Light Formula anti-dandruff conditioner because it failed stability testing. The product is subpotent.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The hazard is subpotency (lack of efficacy) rather than toxicity or injury.
Plain-English summary
J. Strickland and Co is recalling Sulfur8 Medicated Light Formula (sulfur) anti-dandruff hair & scalp conditioner, 2%. The recall involves 1,170 cases of the product, packaged in 2 OZ (57g) jars (UPC 0 75610 43510 8) and 4 OZ (113g) jars (UPC 0 75610 43610 5). The specific lot number is 33UF.
The recall was initiated because the product is subpotent, meaning it failed at the 3 and 6-month stability time points. This indicates the medication may not be effective for its intended purpose.
The product was distributed nationwide, as well as in Jamaica and the Bahamas. Consumers should stop using the product and contact the manufacturer for instructions on how to return it or obtain a refund.
The recalled product
- Product
- sulfur8 medicated LIGHT FORMULA (sulfur) anti-dandruff hair & scalp conditioner, 2%, packaged in a) 2 OZ (57g) jar (UPC 0 75610 43510 8), and b) 4 OZ (113g) jar (UPC 0 75610 43610 5), 1 dozen jars per case, J. Strickland & Co., PO Box 1637, Olive Branch, MS 38654
- Manufacturer
- J. Strickland and Co
- Category
- Drug — Topical Medication
- Hazard
- Affected units
- 1,170
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 33UF
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · J. Strickland and Co
See all →- LowSulfur8 Medicated Anti-Dandruff Conditioner Recalled for pH Specification Failure
FDA (Drugs) · 2014-12-31
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02